Albumin versus balanced crystalloid for resuscitation in the treatment of sepsis: A protocol for a randomised controlled feasibility study, “ABC-Sepsis”

Jack Cafferkey, Andrew Ferguson, Julia Grahamslaw, Kat Oatey, John Norrie, Nazir I Lone, Timothy S. Walsh, Daniel Horner, Andy Appelboam, Peter S Hall, Richard Skipworth, Derek Bell, Kevin D Rooney, Manu Shankar-Hari, Alasdair Corfield, Alasdair Gray

Research output: Contribution to journalArticlepeer-review

Abstract

Background
Patients presenting with suspected sepsis to secondary care often require fluid resuscitation to correct hypovolaemia and/or septic shock. Existing evidence signals, but does not demonstrate, a benefit for regimes including albumin over balanced crystalloid alone. However, interventions may be started too late, missing a critical resuscitation window.
Methods
ABC Sepsis is a currently recruiting randomised controlled feasibility trial comparing 5% human albumin solution (HAS) with balanced crystalloid for fluid resuscitation in patients with suspected sepsis. This multicentre trial is recruiting adult patients within 12 hours of presentation to secondary care with suspected community acquired sepsis, with a National Early Warning Score ≥5, who require intravenous fluid resuscitation. Participants are randomised to 5% HAS or balanced crystalloid as the sole resuscitation fluid for the first 6 hours.
Objectives
Primary objectives are feasibility of recruitment to the study and 30-day mortality between groups. Secondary objectives include in-hospital and 90-day mortality, adherence to trial protocol, quality of life measurement and secondary care costs.
Discussion
This trial aims to determine the feasibility of conducting a trial to address the current uncertainty around optimal fluid resuscitation of patients with suspected sepsis. Understanding the feasibility of delivering a definitive study will be dependent on how the study team are able to negotiate clinician choice, Emergency Department pressures and participant acceptability, as well as whether any clinical signal of benefit is detected.
Original languageEnglish
JournalJournal of the Intensive Care Society
Early online date30 May 2022
DOIs
Publication statusE-pub ahead of print - 30 May 2022

Fingerprint

Dive into the research topics of 'Albumin versus balanced crystalloid for resuscitation in the treatment of sepsis: A protocol for a randomised controlled feasibility study, “ABC-Sepsis”'. Together they form a unique fingerprint.

Cite this